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A cognitive electrophysiological signature
differentiates amnestic mild cognitive
impairment from normal aging
Juan Li1,2*, Lucas S. Broster2, Gregory A. Jicha3,4, Nancy B. Munro5, Frederick A. Schmitt2,3,4, Erin Abner3,6,
Richard Kryscio3,7,8, Charles D. Smith3,4 and Yang Jiang2,3*

Abstract
Background: Noninvasive and effective biomarkers for early detection of amnestic mild cognitive impairment
(aMCI) before measurable changes in behavioral performance remain scarce. Cognitive event-related potentials
(ERPs) measure synchronized synaptic neural activity associated with a cognitive event. Loss of synapses is a
hallmark of the neuropathology of early Alzheimer’s disease (AD). In the present study, we tested the hypothesis
that ERP responses during working memory retrieval discriminate aMCI from cognitively normal controls (NC)
matched in age and education.
Methods: Eighteen NC, 17 subjects with aMCI, and 13 subjects with AD performed a delayed match-to-sample task
specially designed not only to be easy enough for impaired participants to complete but also to generate comparable
performance between subjects with NC and those with aMCI. Scalp electroencephalography, memory accuracy, and
reaction times were measured.
Results: Whereas memory performance separated the AD group from the others, the performance of NC and subjects
with aMCI was similar. In contrast, left frontal cognitive ERP patterns differentiated subjects with aMCI from NC. Enhanced
P3 responses at left frontal sites were associated with nonmatching relative to matching stimuli during working memory
tasks in patients with aMCI and AD, but not in NC. The accuracy of discriminating aMCI from NC was 85% by using left
frontal match/nonmatch effect combined with nonmatch reaction time.
Conclusions: The left frontal cognitive ERP indicator holds promise as a sensitive, simple, affordable, and noninvasive
biomarker for detection of early cognitive impairment.
Keywords: Amnestic mild cognitive impairment, Alzheimer’s disease, Event-related potentials, Working memory, Early
detection

Background
Detection of brain changes that precede clinical Alzheimer’s
disease (AD) has been a major public health goal owing to
the rapidly increasing proportion of the population that is
at risk of developing the debilitating illness. Mild cognitive
impairment (MCI) is a transitional state between normal
aging and dementia. In turn, amnestic mild cognitive
impairment (aMCI), a subtype of MCI, has been
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conceptualized as significant (episodic) memory decline
along with relatively preserved global cognition and intact
activities of daily living. Individuals with aMCI have a high
risk of progression to AD [1]. Neuroimaging biomarkers for
early detection of cognitive decline have proven vitally
important for emerging interventions that successfully slow
progression to AD and for targeting likely MCI/AD
converters in clinical trials [2]. However, many of the
neuroimaging methods for early detection are expensive,
invasive, and require specially trained medical staff [3].
Electroencephalography (EEG), a technique that measures summations of neural postsynaptic potentials at the
scalp, has been available for several decades. Averaged
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EEG signals associated with cognitive events, known as
event-related potentials (ERPs), are a well-studied
approach for indexing brain mechanisms underlying
memory and cognition. Altered ERP signals, either in
amplitude or in latency, in patients with AD have also
been reported by many groups around the world [4].
Despite this, the science of using cognitive ERPs as
biomarkers remains in its infancy.
Recent work has revealed that neurosynaptic changes
appear before tau-mediated neuronal injury or brain
structure changes and are one of the earliest markers of
preclinical AD [5]. Measures of EEG, which directly
measures postsynaptic potentials, are sensitive to these
early changes and may advance the early detection and
diagnosis of “presymptomatic” AD (that is, detection of
AD before the appearance of any clinical symptoms
whatsoever) [6]. In addition to measuring these early
synaptic function changes sensitively, ERP is also less
expensive and less invasive than other well-studied early
diagnostic biomarkers, such as cerebrospinal fluid (CSF)
measurement or imaging with positron emission tomography (PET). Therefore, the primary goal of the present
study was to assess the viability of cognitive ERPs as
indicators of aMCI.
In addition to the well-known episodic memory
impairments, studies have emphasized that working
memory and executive function are also affected early in
the course of AD [7]. In order to probe working memory
deficits, participants were required to perform a version
of a delayed match-to-sample (DMS) task that has been
used extensively in working memory studies in both primates [8] and humans [9]. In a typical implementation
of the DMS task, each trial begins with the presentation
of a sample item; then, after a brief delay, items that
either match or do not match the sample appear one by
one. The participant’s task is to indicate whether each
test item matches the prior sample item. Enhanced
neural responses in the frontal cortex have been linked
to the judgment of whether an item matches the sample
in a functional magnetic resonance imaging (fMRI) study
[9]. In turn, this judgment has similarly been linked to
greater positive P3 component with a scalp distribution
maximal at the frontal and central areas that was
source-localized to prefrontal and frontal sites in an ERP
study [10]; in related studies, this ERP effect showed
sensitivity to the course of cognitive aging at frontal sites
[11, 12]. Together, these findings implicate a frontal P3
component as an EEG indicator of the working memory
status of visually presented items.
Although previous studies have shown that ERP measures can differentiate persons with aMCI from those
without impairment [13–21], little is known about
whether these measures might capture neural activity
differences in the absence of explicit performance
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impairment. In order to generate and test such a circumstance, we employed an easier version of the DMS
task that included fewer test images per trial, fewer
blocks, and increased test item presentation time. These
steps also allowed participants who had been diagnosed
with mild AD to participate in the task, potentially enabling linkage of the neural signatures associated with
aMCI to those of AD.
The objectives of the present study were (1) to test
whether the frontal ERP signature during working memory
differentiates patients with aMCI from normal controls
(NC) who are matched in age, education, and performance;
(2) to test the progression of the cognitive ERP signature in
a group of patients with early AD; and (3) to assess the discrimination accuracy of the ERP signature as a biomarker
of disease progression.

Methods
Participants

Participants were 18 NC (7 male, 11 female) between the
ages of 67 and 83 years (mean = 75.11, SD = 4.95), 16 with
aMCI (11 male, 5 female) between the ages of 62 and
90 years (mean = 75.31, SD = 9.21), and 13 patients with
AD (5 male, 8 female) between the ages of 66 and 82 years
(mean = 75.77, SD = 5.67). The three groups did not differ
in age [F(2,46) = 0.035, p = 0.97], sex distribution
[χ2(2) = 3.73, p = 0.16], or years of education (NC
group mean =16.22, SD = 3.02; aMCI group mean =
16.86, SD = 1.96; AD group mean = 17.23, SD = 3.72)
[F(2,46) = 0.478, p = 0.62]. The mean Mini Mental
State Examination scores were 29.31 (SD = 0.75, range
28–30) for the NC group, 27.83 (SD = 1.80, range 25–30)
for the aMCI group, and 24.44 (SD = 2.76, range 20–29)
for the AD group. Mean scores in the AD group were
significantly lower than in the NC and aMCI groups
(p < 0.001).
All participants were community-dwelling individuals
who were right-handed and had normal or corrected-tonormal visual acuity. Participants were recruited from
the University of Kentucky Alzheimer’s Disease Center
(UK-ADC) longitudinal normal volunteer cohort [22, 23].
Inclusion criteria for this cohort are a minimum age of
65 years, cognitive and neurological normality at
enrollment, agreement to brain donation to the UK-ADC
at death, a designated informant for structured interviews,
and willingness to undergo annual examinations. Participants were excluded from the cohort if they had a history
of substance abuse, major psychiatric illness, or neurological disease. The annual evaluation includes a comprehensive neuropsychological battery and general
physical and neurological examinations that are
detailed elsewhere [24, 25].
If any of the following occurs, a cohort participant is
evaluated with a more detailed cognitive assessment and
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formal clinical assessment by study physicians: (1)
diagnosis by the examining physician of conversion to
MCI or dementia; (2) suspicion of cognitive decline on
the part of the supervising neuropsychologist and/or objective decline in the form of annual memory test score
1.5 SD below the previous annual assessment, which is
done annually in the UK-ADC consensus conference
review [24]; (3) prescription of a cholinesterase inhibitor,
N-methyl-D-aspartate antagonist, or other treatment
associated with the medical diagnosis of dementia by an
outside physician; or (4) evidence of functional impairment secondary to cognitive decline from the participant
or an informant. The UK-ADC consensus conference
reviews these data and a diagnosis of normal, aMCI
[1, 26–28], or AD [29] is assigned in accordance with the
National Alzheimer’s Coordinating Center’s Uniform Data
Set procedures [30]. After conversion to aMCI or AD,
each cohort member participated in the present study’s
EEG protocols as soon as their scheduling permitted (i.e.,
most often within 1 month of diagnosis).
EEG and behavioral data analyses performed with a
subset of this cohort have been published previously
[25, 31, 32]. All participants provided written
informed consent before participation. This study was
approved by the institutional review board (IRB) of
the University of Kentucky.
Working memory task: DMS task

Participants were instructed to memorize a sample
image and then indicate whether each of five serially
presented objects matched the sample image (Fig. 1)
[31]. Stimuli consisted of 120 two-dimensional common
objects taken from Snodgrass and Vanderwart [33]. Each
picture was presented with a black background and
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within an area of 8.3 cm × 5.8 cm. All stimuli were
presented on a high-resolution color monitor using EPrime software (Psychology Software Tools, Sharpsburg,
PA, USA). Stimuli were presented at a 65-cm visual
distance and a visual angle of approximately 7 degrees.
Test images were normalized across retrieval status (i.e.,
matching or nonmatching) for image familiarity and
image complexity [33].
ERP recording

ERP recordings were obtained from 62 scalp sites using
Ag/AgCl electrodes embedded in an elastic cap at
locations from the extended international 10–20 system.
These electrodes were referenced to a midline reference
electrode during recording and re-referenced to the
average of the right and left mastoid potentials offline.
Two additional channels were used for monitoring
horizontal and vertical eye movements. Impedance was
maintained below 5 kΩ. EEG data were filtered using a
band-pass of 0.05–40 Hz and sampled at a rate of
500 Hz. Each averaging epoch lasted 1100 milliseconds,
including 100 milliseconds prior to stimulus onset. A
regression algorithm implemented with NeuroScan
software (Compumedics, Abbotsford, Australia) was
used to reduce the influence of blink artifact on the
EEG waves. Epochs associated with inaccurate
responses or contaminated by electro-ocular artifacts
were excluded from analysis.
Data analysis

Behavioral results were indexed using accuracy and
response times (RTs) of correct responses. The accuracy
and RT data were subjected to two-way analysis of
variance (ANOVA) with the between-subjects factor of

Fig. 1 Schematic representing a trial in the delayed match-to-sample task. A sample image with a green border was initially presented for 3 seconds. After a jittered delay (1.1–1.4 seconds), the participant indicated whether each of five successive test images matched or did not match the
sample. A new sample image was used in each trial. Individual images (either matching or nonmatching) were tested two or three times per trial.
Each working memory (WM) trial lasted approximately 16 seconds. Altogether, 60 trials were performed in 2 blocks of 30 trials each, with a short
break between blocks. The working memory task lasted approximately 18 minutes overall
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group (NC, aMCI, AD) and the within-subjects factor of
experimental condition (match, nonmatch).
On the basis of visual inspection of the grand average
waveforms and previous studies [13–15], the P3 match
vs. nonmatch effect was quantified by calculating the
mean amplitude in the 300- to 600-millisecond time
window. An omnibus ANOVA was performed over 6
scalp regions involving 18 electrode sites: left frontal (F3,
F5, F7), right frontal (F4, F6, F8), left central (C3, F5,
T7), right central (C4, C6, T8), left parietal (P3, P5, P7),
and right parietal (P4, P6, P8). The factors of this omnibus
ANOVA included group (NC, aMCI, AD), experimental
condition (match, nonmatch), electrode factors of
hemisphere (left, right), anterior-posterior orientation
(frontal, central, parietal), and medial-lateral orientation
(inferior, middle, superior). Only significant main effects
or interactions involving the factors of match/nonmatch
and/or group were reported. In addition, planned group
comparisons between NC vs. aMCI and aMCI vs. AD on
the match vs. nonmatch effects were carried out at the
frontal areas. Finally, group discrimination was performed
to assess how well the ERP modulation could differentiate
aMCI from NC.
Greenhouse-Geisser correction for nonsphericity of
data was applied as necessary. The uncorrected degrees
of freedom, the corrected p values, and the effect sizes
(η2p) are reported. p Values of follow-up pairwise
contrasts were adjusted using the Bonferroni correction.
For all analyses, the significance level was set to 0.05.

Results
Behavioral results
Accuracy

Mean accuracy for each group as a function of match/
nonmatch are presented in Table 1. ANOVA revealed a
main effect of group [F(2,44) = 10.99, p < 0.001, η2p = 0.33].
Post hoc comparisons revealed that participants with AD
performed worse than those in the NC and aMCI groups
(p < 0.01), but no significant differences were found
between the NC and aMCI groups.

Table 1 Mean accuracy and mean reaction time (ms) for each
response category in three groups (standard deviations of the
mean)
Group

Accuracy

RT in milliseconds, mean (SD)

Match

Nonmatch

Match

NC

0.98 (0.16)

0.99 (0.15)

599 (78)

Nonmatch
648 (90)

aMCI

0.95 (0.08)

0.98 (0.03)

604 (155)

696 (130)

AD

0.89 (0.10)

0.85 (0.18)

720 (130)

804 (151)

AD Alzheimer’s disease, aMCI Amnestic mild cognitive impairment, NC Normal
controls, RT response time

Response times

Concerning response times (Table 1), ANOVA revealed significant main effects of match/nonmatch [F(1,44) = 99.93,
p < 0.001, η2p = 0.69] and group [F(1,2) = 5.35, p < 0.01, η2p =
0.20], as well as a two-way match/nonmatch × group
interaction [F(2,44) = 3.28, p < 0.05, η2p = 0.13]. Nonmatch
responses were associated with slower RT than responses
in the match condition. Participants with AD responded
more slowly than those in the NC and MCI groups. The
significant match/nonmatch × group interaction reflected
these group differences being larger in the nonmatch
condition than in the match condition.
Summary

Although patients with AD performed more slowly and
less accurately than participants in the aMCI and NC
groups, the NC and aMCI groups did not differ significantly in either RT or accuracy. These results suggested
that the performance between NC and aMCI on the easier
task was comparable as planned, whereas patients with
dementia performed significantly worse than these groups.
ERP results

The grand average ERPs evoked by correct responses to
match and nonmatch objects are shown for all three
groups in Fig. 2. The NC group showed the typical P3
match enhancement seen in previous studies [10–12],
maximal at right central areas. In addition to the typical
P3 match enhancement, a unique and striking feature
shown in the aMCI and AD groups was at the left frontal
sites, where the nonmatch condition elicited a larger P3.
This impression was further verified by evaluating the
topographic current source density maps of the difference
waveforms by match minus nonmatch (Fig. 3).
Omnibus ANOVA

Omnibus ANOVA revealed significant two-way interactions of match/nonmatch × hemisphere [F(1,88) = 31.70,
p < 0.001, η2p = 0.419] and match/nonmatch × anterior-posterior orientation [F(2,88) = 13.19, p < 0.001, η2p = 0.231], as
well as significant three-way interactions of match/nonmatch × hemisphere × group [F(2,88) = 3.78, p = 0.031,
η2p = 0.147] and match/nonmatch × hemisphere × anterior-posterior orientation [F(2,88) = 3.83, p = 0.040,
η2p = 0.080].
Follow-up analyses for the match/nonmatch × hemisphere × anterior-posterior orientation three-way interaction revealed that in the left hemisphere, the
amplitudes elicited by the nonmatch condition were
larger than the match condition (frontal sites match −
nonmatch = 2.791 − 3.784 = −0.993 μV; central sites
match − nonmatch = 2.957 − 3.033 = −0.076 μV; parietal
sites match − nonmatch = 3.298 − 3.445 = −0.147 μV).
The match/nonmatch effect reached significance in the
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Fig. 2 Grand average waveforms elicited by correctly classified match objects and by correctly classified nonmatch objects from −100 milliseconds
to +1000 milliseconds in (a) the normal control (NC) group, (b) the amnestic mild cognitive impairment (aMCI) group, and (c) the Alzheimer’s disease
(AD) group. Electrode sites are indicated by the inserted montage (F, C, and P stand for frontal, central, and parietal regions on the scalp, respectively).
Positive voltages are plotted upward

Fig. 3 The spatial distribution of current source density (in microvolts per square meter) of match/nonmatch effects (formed by subtracting event-related
potentials [ERPs] of nonmatch from ERPs of match) in three groups for each 100 milliseconds within 0- to 800-millisecond latency regions. AD Alzheimer’s
disease, aMCI Amnestic mild cognitive impairment, NC Normal controls
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frontal region (p = 0.01); in the right hemisphere, more
positive-going ERPs for the match condition than for
nonmatch were observed, and the match/nonmatch effects reached significance in all three regions, with a
trend of being larger at the posterior region than in the
anterior region (frontal sites match − nonmatch = 4.263
− 3.656 = 0.607 μV; central sites match − nonmatch =
4.305 − 2.560 = 1.745 μV; parietal sites match − nonmatch = 4.070 − 3.234 = 0.836 μV).
The three-way match/nonmatch × hemisphere × group
interaction was further analyzed by exploring the match/
nonmatch effect in each hemisphere within each group. In
the NC group, the match condition was more positivegoing than the nonmatch in both hemispheres, but the
differences reached significance only in the right
hemisphere (match − nonmatch = 5.468 − 4.447 = 1.021 μV;
p < 0.001). In the aMCI group, the nonmatch stimuli
elicited larger positive amplitudes than the match
condition at the left side (match − nonmatch = 1.931 −
2.957 = −1.026 μV, p = 0.01), whereas more positivegoing ERPs were observed with match than nonmatch
at right hemisphere (match − nonmatch = 3.383 −
2.010 = 1.373 μV; p < 0.01). The pattern of working
memory effects in the AD group presented in a
similar way as in the aMCI group, albeit with smaller
magnitudes.
Planned comparisons

Group comparisons on grand average waveforms and
mean amplitudes of match/nonmatch effects at frontal
region are shown in Fig. 4.
Planned group comparisons were conducted to directly compare groups on the match/nonmatch effect
within the frontal sites (i.e., left frontal at F3, F5, and F7;
right frontal at F4, F6, and F8). Group × match/nonmatch × hemisphere ANOVA revealed a significant main
effect of group [F(2,44) = 3.51, p < 0.05, η2p = 0.14], a
significant
two-way
hemisphere × match/nonmatch
interaction [F(1,44) = 26.92, p < 0.001, η2p = 0.38], and
three-way group × hemisphere × match/nonmatch interaction [F(2,44) = 4.28, p < 0.05, η2p = 0.16]. In each hemisphere, the planned NC/aMCI and aMCI/AD group
comparisons were conducted on the match/nonmatch
effect, computed as match − nonmatch. At the left site,
the magnitudes of the working memory effect were
−0.026 μV in the NC group, −1.865 μV in the aMCI
group, and −1.087 μV in the AD group; the difference
between NC and aMCI reached significance (p < 0.05),
whereas the difference between aMCI and AD was not
significant. At the right side, the magnitudes of match/
nonmatch effect were 0.709 μV in the NC group,
0.926 μV in the aMCI group, and 0.186 μV in the AD
group. At the right site, neither of the group comparisons was significant.

Fig. 4 a Grand average waveforms from lateral frontal regions
elicited by correctly classified match and nonmatch items in three
groups. The left frontal (F) region was collapsed across F3, F5, and
F7, and the right frontal site was collapsed across F4, F6, and F8. The
selected electrode sites are indicated by the inset. b Mean amplitude
of match/nonmatch effects (match − nonmatch) at left and right
frontal regions (300–600 milliseconds) according to group. Error bars
represent SEM. Asterisk denotes significant group difference between
NC and aMCI at left frontal region. AD Alzheimer’s disease, aMCI
Amnestic mild cognitive impairment, NC Normal controls

Summary

In the right hemisphere, a similar P3 match enhancement
was found in all three groups, whereas in left frontal areas,
a reversed pattern (i.e., P3 nonmatch enhancement) was
observed in both the aMCI and AD groups, with a larger
such effect seen in the aMCI group.
Group discrimination

On the basis of a planned comparison finding of significant differences between aMCI and NC at the left frontal
region, the match/nonmatch difference (i.e., match − nonmatch) from 300 to 600 milliseconds at the left frontal
area collapsed over F7, F5, and F3 was adopted as one
factor for discrimination analysis. In addition, given that
the response times of NC and aMCI became divergent for
the nonmatch condition, nonmatch RT was selected as
another factor for discrimination analysis. As shown in
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Fig. 5, by using −0.39-μV and 550-millisecond cutoffs for
match/nonmatch effect and nonmatch RT, respectively,
the sensitivity was 14/16 = 87.5%, the specificity was 15/
18 = 83.3%, and the group discrimination was (14 + 15)/
(16 + 18) = 85.3%.

Discussion
We tested whether cognitive ERP during a working
memory task could discriminate aMCI from normal older
adults who were well-matched in age, education, and
behavioral performance. We found a left frontal ERP
signature associated with working memory to be a potentially effective ERP biomarker indicating cognitive decline
before measureable changes in behavioral testing.
Brain regions involved in DMS task

The network of brain regions is involved during the
working memory task, regardless of whether visual
objects are trial-unique stimuli. The stimuli for the DMS
task trial were unique in the present study. Stimuli
consisted of 120 two-dimensional common objects. For
each of the 60 trials, a new visual object functioned as
the target match. Different objects were used as nontarget/nonmatch distractors. The matches and nonmatches
were trial-unique. An object was repeated only within a
trial. In a previous fMRI study [9], the small set of

Fig. 5 Group discrimination of amnestic mild cognitive impairment
(aMCI) from normal controls (NC). Scatterplot of individual subject
data for the match/nonmatch effect (mean amplitude difference
between 300 and 600 milliseconds at left frontal [F] region collapsed
across F7, F5, and F3 for match − nonmatch) and nonmatch reaction
times (RTs; mean for correctly identified nonmatch items). The
dashed lines indicate cutoff values. With match/nonmatch effect less
than or equal to −0.39 μV and nonmatch RT greater than or equal
to 550 milliseconds, the group discrimination was 85.3%, sensitivity
was 87.5%, and specificity was 83.3%
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30-plus stimuli were studied by the healthy young participants before fMRI scanning. The stimuli were not
unique for memory type or unique for each trial. That
is, the same visual item can be a memory target match
in one trial and a distractor in the next trial. Thus, working memory status but not familiarity is responsible for
the cortical responses. Both prefrontal and temporal
cortices (hippocampal and parahippocampal) were
involved in the DMS task, with match enhancement
dominating in prefrontal cortex (Brodmann areas BA46,
BA47, and BA9). These results were consistent with
those for monkey physiology. For studies involving older
adults and patients, we developed the shorter DMS task
for clinical application under either EEG or fMRI
environments. As the paradigm used in the present
study, healthy older adults participated in a DMS task
that used unique stimuli for each trial [34]. A network of
cortical regions including medial temporal, parietal and
prefrontal cortices were engaged in these DMS tasks.

Frontal compensation and left frontal ERP signature in
aMCI

In the right hemisphere, we found enhanced neural
responses for target compared with nonmatch responses
in all three groups. In addition, in a previous study, we
used a similar DMS paradigm applied to young participants [9]. Likewise, a greater P3 component linked to
match condition was reported in the young group. The
target-related P3 enhancement could be due to the target stimuli being task-relevant and consequently requiring more attentional resources than nontarget stimuli. It
should be noted that in our previous study, the match
condition took longer for young participants to respond,
whereas in the present study, we found that the reaction
time of nonmatch was longer than that of match for
three aged groups. Furthermore, although the impaired
groups’ responses were generally slower, compared with
match condition, under the nonmatch condition the
group differences tended to become larger. By combining the results from both our previous study and the
present study, we concluded that rejecting a distractor
became difficult when people got older and even more
difficult when MCI appeared during old age, so that the
MCI evoked larger left frontal responses of nonmatch
vs. match as a compensation mechanism to counteract
their impaired ability to inhibit the distractors. As the
disease further progressed, a disruption of compensation
was detected in AD, which was linked to their reduced
performance. These findings were consistent with literature showing that persons with MCI recruit more neural
resources than persons without impairment in various
cognitive tasks, including memory and attention, to try
to compensate for their cognitive deficits [35].
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We found that this left frontal ERP signature, together
with the nonmatch RT in a DMS task, provided a
discrimination accuracy of 85%. Given that this task took
only about 18 minutes and EEG recording is a method
less expensive and/or less invasive than some other
biomarkers, such as magnetic resonance imaging, PET,
and CSF sampling, we suggest that this cognitive ERP
marker may serve as a dynamic biomarker that could be
used before explicit changes in memory performance are
measurable or structural changes are seen in the brain.
Early AD pathology and ERPs of synaptic dysfunction

One of the hallmarks of early AD pathology is synaptic
loss in the hippocampus and neocortex at the medial
temporal cortices in persons with MCI or AD [36].
Previous published neuropathological work on other participants in the UK-ADC longitudinal cohort has implicated
loss of afferents from the entorhinal cortex to frontal and
parietal regions in the progress of AD [37, 38]. Such afferents are known to be implicated in the instantiation of
working memory through short-term synaptic facilitation,
and the working memory task used in the present study is
known to incorporate prefrontal resources as task difficulty
increases through incorporation of additional distractors [39, 40]. Thus, we suggest that the left frontal
match/nonmatch effect has good face validity as a
cognitive biomarker of early AD and reflects cognitive
compensation for the nonmatch working memory
condition, which is associated with greater difficulty
in the early course of clinical AD [31].
Future directions

This study was limited by its small sample size and
cross-sectional nature. In future work, we aim to validate the current ERP biomarker with a larger sample size.
In addition, we will follow the NC and aMCI individuals
to confirm the validity of this simple and noninvasive
biomarker through within-subject conversions. Because
the participants in the present study were UK-ADC
volunteers who have agreed to donate their brains for
postmortem pathological assessment, the relationship of
the cognitive ERPs found in this and future studies to
the neuropathological correlates of aMCI and AD will
be also validated after autopsy.

Conclusions
By use of a DMS task, we found a unique P3 nonmatch
enhancement effect in persons with aMCI despite
comparable memory performance on this task relative to
the NC group. We suggest that this indexes compensation for impaired rejecting of distractor stimuli in aMCI
and that disruption of this compensation mechanism in
AD was linked to their reduced performances. This left
frontal ERP modulation provides a sensitive, noninvasive,
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and less expensive neurosignature for early detection
of aMCI.
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